PSPH expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.549400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.850400E-01
Normal-vs-Stage2
8.778400E-01
Normal-vs-Stage3
8.497700E-02
Normal-vs-Stage4
4.338400E-01
Stage1-vs-Stage2
5.673600E-02
Stage1-vs-Stage3
5.227600E-02
Stage1-vs-Stage4
1.590800E-01
Stage2-vs-Stage3
7.822200E-02
Stage2-vs-Stage4
3.220400E-01
Stage3-vs-Stage4
3.251200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.706000E-01
Normal-vs-AfricanAmerican
2.093000E-01
Normal-vs-Asian
8.688600E-01
Caucasian-vs-AfricanAmerican
7.904400E-02
Caucasian-vs-Asian
9.485200E-01
AfricanAmerican-vs-Asian
7.687900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.863800E-01
Normal-vs-Female
8.155800E-01
Male-vs-Female
5.995800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.749600E-01
Normal-vs-Age(41-60Yrs)
4.964600E-01
Normal-vs-Age(61-80Yrs)
8.419000E-01
Normal-vs-Age(81-100Yrs)
7.995600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.121030E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.950400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.463600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.028400E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.432230E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.399000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.412800E-01
Normal-vs-Daily Drinker
6.408200E-01
Normal-vs-Weekly Drinker
9.613600E-01
Normal-vs-Occasional Drinker
5.538000E-01
Normal-vs-Social Drinker
5.135400E-01
Non Drinker-vs-Daily Drinker
8.146200E-01
Non Drinker-vs-Weekly Drinker
5.062000E-01
Non Drinker-vs-Occasional Drinker
8.012200E-02
Non Drinker-vs-Social Drinker
8.205700E-02
Daily Drinker-vs-Weekly Drinker
4.104600E-01
Daily Drinker-vs-Occasional Drinker
6.244200E-02
Daily Drinker-vs-Social Drinker
6.524200E-02
Weekly Drinker-vs-Occasional Drinker
2.920200E-01
Weekly Drinker-vs-Social Drinker
2.508600E-01
Occasional Drinker-vs-Social Drinker
9.035200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.730000E-01
Normal-vs-Grade 2
8.860200E-01
Normal-vs-Grade 3
9.970200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.728400E-02
Grade 1-vs-Grade 3
6.034000E-01
Grade 1-vs-Grade 4
8.730000E-01
Grade 2-vs-Grade 3
7.520100E-02
Grade 2-vs-Grade 4
8.860200E-01
Grade 3-vs-Grade 4
9.970200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.057400E-01
Normal-vs-NonDiabetic
7.375600E-01
Diabetic-vs-NonDiabetic
3.640300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.100800E-01
Normal-vs-NoPancreatitis
8.765200E-01
Pancreatitis-vs-NoPancreatitis
4.823200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.387800E-01
Normal-vs-N1
8.879000E-01
N0-vs-N1
8.262800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.525200E-01
Normal-vs-TP53-NonMutant
5.020000E-01
TP53-Mutant-vs-TP53-NonMutant
7.633400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
